Politics and Government Politics and Government

Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio's Bridgewater Is Crazy About?


Published on 2024-12-02 17:01:18 - Thomas Matters, WOPRAI
  Print publication without navigation

  • We recently compiled a list of the Billionaire Ray Dalio's Bridgewater Is Crazy About These 15 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Ray Dalio's Bridgewater is crazy about.

The article discusses why Merck & Co., Inc. (MRK) is a favored stock among Ray Dalio's hedge fund, Bridgewater Associates. Merck has shown robust financial performance with a 7% year-over-year revenue increase in Q1 2024, driven by strong sales of its cancer drug Keytruda and vaccines like Gardasil. The company's strategic focus on oncology, with Keytruda expected to remain a significant revenue driver until at least 2028, underpins its attractiveness. Additionally, Merck's pipeline includes promising new treatments, and its recent acquisitions, like Prometheus Biosciences, are aimed at expanding its immunology portfolio. Bridgewater's interest in Merck also reflects confidence in the company's ability to navigate patent expirations and maintain growth through innovation and strategic acquisitions.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/other/why-is-merck-co-inc-mrk-among-the-stocks-ray-dalio-s-bridgewater-is-crazy-about/ar-AA1v7ppq ]